By Joao Manuel Vicente Mauricio, Ankika Biswas and Johann M Cherian

(Reuters) -European closed at a fresh one-month high on Wednesday, with German stocks finishing above the 20,000 mark, while attention was on France where a no-confidence vote in parliament was likely oust Prime Minister Michel Barnier’s government.

The pan-European index closed higher by 0.3% and notched its fifth straight session of advances, with retail stocks leading sectoral advances by 2.2%.

40 closed up 0.6% as the debate on the no-confidence motion was underway ahead of the vote due around 1830-1900 GMT.

Barnier’s three-month old fragile government is expected to be forced out at a time when the country is struggling to tame a massive budget deficit, and French President Emmanuel Macron said he aims to install a new prime minister quickly if his government falls.

“There is clearly a decent level of uncertainty and division within France around the right way forward,” said Richard Flax, chief investment officer at Moneyfarm.

“Whatever budget gets eventually put forward, or even whether (the current budget) is rolled over, the challenge of resolving these fiscal and debt dynamics is that it is a multi-year process.”

France’s political uncertainty also hit its services sector, data showed, while the euro zone’s business activity fell sharply.

Political chaos in France has weighed on the CAC 40 which is down over 3% this year and is the top decliner among peers. The euro has lost over 4% this year, while spreads between French and German bonds have widened to a 12-year high.[GVD/EUR]

On Tuesday, rose 1% and closed above the 20,000-point mark for the first time, boosted by SAP’s 3.7% advance.

Among others, Vestas bottomed the STOXX index with a 10.9% slide after the Danish wind turbine maker said CFO Hans Martin Smith would step down by end-2024.

Signify lost 4.3% after Barclays (LON:) downgraded the stock of the lighting maker to “underweight” from “overweight”.

Meanwhile, AstraZeneca (NASDAQ:) and Novartis (SIX:) lost around 3% each, dragging down the healthcare index, after HSBC cut the target price of the former and downgraded the latter to “reduce” from “hold”.

Hugo Boss (ETR:) surged 9.7% after Baader Helvea upgraded its rating on the German fashion house to “buy” from “add”.

© Reuters. The German share price index DAX graph is pictured after the German index reached an all-time-high with over 20,000 points at the stock exchange in Frankfurt, Germany, December 3, 2024. REUTERS/Staff

Hexagon jumped 7.8% after the company proposed the former CEO of ABB (ST:) and Sandvik as the new vice chairman.

The auto sector was among top sectoral gainer, with Stellantis (NYSE:) rising 1.3% after a report said that Apple (NASDAQ:)’s outgoing CFO could become the new CEO of the Italian-French carmaker. However, the company later denied these claims.


Source link

Best Brokers

Unmatched trading fees, generous bonuses, top notch Regulation Frame.

T&Cs Apply

Risk disclosure: All investments involve a degree of risk of some kind. Trading financial derivative products comes with a high risk of losing money rapidly due to leverage.

Top-Tier Regulations. Unmatched Spreads and Commissions. Trading View is available.

T&Cs Apply

Financial Spread Trades and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 84.7% of retail investor accounts lose money when trading CFDs with this provider.

Modern and Intuitive Interfaces, Solid Regulatory Frame, and excellent Trading Fees.

T&Cs Apply
Risk warning: Trading derivatives is highly speculative, carries an inherent risk of loss and is not suitable for all investors. Before trading, you are strongly advised to read and ensure that you understand the relevant risk disclosures and warnings.

Highly Regulated. Low Spreads and Commissions. Vast Account Options.

T&Cs Apply

Risk Warning: Trading derivatives carries significant risks. It is not suitable for all investors and if you are a professional client, you could lose substantially more than your initial investment.